Substrate analogues to study cell-wall biosynthesis and its inhibition

Current Opinion in Chemical Biology

Volumn 6, Issue 6, 2002, Pages 786-793

  Lazar, Kristi ^a   Walker, Suzanne ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MERSACIDIN; NISIN; PEPTIDOGLYCAN; RAMOPLANIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; GLYCOSYLTRANSFERASE; LIPID I; MONOSACCHARIDE; MURAMYL NAC (PENTAPEPTIDE)PYROPHOSPHORYL UNDECAPRENOL; MURAMYL-NAC-(PENTAPEPTIDE)PYROPHOSPHORYL-UNDECAPRENOL; OLIGOPEPTIDE; URIDINE DIPHOSPHATE N ACETYLMURAMIC ACID;

BIOSYNTHESIS; CELL WALL; DRUG BINDING; REVIEW; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMISTRY; DRUG EFFECT; ENZYME SPECIFICITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LIPID METABOLISM; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CELL WALL; GLYCOSYLTRANSFERASES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LIPID METABOLISM; LIPIDS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MONOSACCHARIDES; OLIGOPEPTIDES; PEPTIDOGLYCAN; PROTEIN BINDING; SUBSTRATE SPECIFICITY; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

EID: 0036899030     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(02)00355-1     Document Type: Review

References (47)

1. Ghuysen J-M., Hakenbeck R. Bacterial Cell Wall. 1994;Elsevier Science BV, Amsterdam.
2. Walsh C.T. Molecular mechanisms that confer antibacterial drug resistance. Nature. 406:2000;775-781.
3. Ritter T.K., Wong C-H. Carbohydrate-based antibiotics: a new approach to tackling the problem of resistance. Angew Chem Int Ed Engl. 40:2001;3508-3533.
4. van Heijenoort J. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep. 18:2001;503-519.
5. van Heijenoort J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology. 11:2001;25R-36R.
6. Holtje J-V. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol Mol Biol Rev. 62:1998;181-203.
7. Hitchcock S.A., Eid C.N., Aikins J.A., Zia-Ebrahimi M., Blaszczak L.C. The first total synthesis of bacterial cell wall precursor UDP-N-acetylmuramyl-pentapeptide (Park Nucleotide). J Am Chem Soc. 120:1998;1916-1917.
8. Liu H., Sadamoto R., Sears P.S., Wong C-H. An efficient chemoenzymatic strategy for the synthesis of wild-type and vancomycin-resistant bacterial cell-wall precursors: UDP-N-acetylmuramyl-peptides. J Am Chem Soc. 123:2001;9916-9917. This paper describes an efficient, chemoenzymatic approach to the synthesis of the Park Nucleotide that permits variation in the peptide moiety.
9. Auger G., Crouvoisier M., Caroff M., van Heijenoort J., Blanot D. Synthesis of an analogue of the lipoglycopeptide membrane intermediate I of peptidoglycan biosynthesis. Lett Peptide Sci. 4:1997;371-376.
10. Men H., Park P., Ge M., Walker S. Substrate synthesis and activity assay for MurG. J Am Chem Soc. 120:1998;2484-2485.
11. Ha S., Chang E., Lo M-C., Men H., Park P., Ge M., Walker S. The kinetic characterization of Escherichia coli MurG using synthetic substrate analogues. J Am Chem Soc. 121:1999;8415-8426.
12. 2-α-D-pyranosyl pyrophosphates as potential substrates for the E. coli undecaprenyl-pyrophosphoryl-N-acetylglucoseaminyl transferase MurG. Bioorg Med Chem Lett. 11:2001;3107-3110.
13. Ye X-Y., Lo M-C., Brunner L., Walker D., Kahne D., Walker S. Better substrates for bacterial transglycosylases. J Am Chem Soc. 123:2001;3155-3156. This paper reports the first synthesis of natural Lipid I and natural Lipid II as well as the identification of an optimal substrate for studying transglycosylation.
14. VanNieuwenhze M.S., Mauldin S.C., Zia-Ebrahimi M., Aikins J.A., Blaszczak L.C. The total synthesis of Lipid I. J Am Chem Soc. 123:2001;6983-6988.
15. Chen L., Men H., Ha S., Ye X-Y., Brunner L., Hu Y., Walker S. Intrinsic lipid preferences and kinetic mechanism of Escherichia coli MurG. Biochemistry. 41:2002;6824-6833.
16. Schwartz B., Markwalder J.A., Wang Y. Lipid II: total synthesis of the bacterial cell wall precursor and utilization as a substrate for glycosyltransfer and transpeptidation by penicillin binding protein (PBP) 1b of Eschericia coli. J Am Chem Soc. 123:2001;11638-11643. This paper reports the synthesis of natural Lipid II using a fully chemical route, and also describes the use of this substrate to monitor both transglycosylase and transpeptidase activities in new assay formats.
17. VanNieuwenhze M.S., Mauldin S.C., Zia-Ebrahimi M., Winger B.E., Hornback W.J., Saha S.L., Aikins J.A., Blaszczak L.C. The first total synthesis of lipid II: the final monomeric intermediate in bacterial cell wall biosynthesis. J Am Chem Soc. 124:2002;3656-3660.
18. Lee W., McDonough M.A., Kotra L.P., Li Z-H., Silvaggi N.R., Takeda Y., Kelly J.A., Mobashery S. A 1.2-angstrom snapshot of the final step of bacterial cell wall biosynthesis. Proc Natl Acad Sci USA. 98:2001;1427-1431. This paper describes the crystal structure of a bifunctional penicillin-binding protein complexed with a cephalosporin analogue containing a surrogate meso-DAP-d-Ala-d-Ala chain. The analogue was designed to probe the mechanism of the cross-linking reaction catalyzed by transpeptidases.
19. Ha S., Walker D., Shi Y., Walker S. The 1.9 Å crystal structure of Escherichia coli MurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis. Protein Sci. 9:2000;1045-1052.
20. Eggert U.S., Ruiz N., Falcone B.V., Branstrom A.A., Goldman R.C., Silhavy T.J., Kahne D. Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin. Science. 294:2001;361-364. A gene involved in the regulation of peptidoglycan biosynthesis was discovered in a search for mutants resistant to inhibitors of the transglycosylation step of peptidoglycan synthesis. It was proposed that there is a genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin in Gram-positive organisms as well as in E. coli.
21. Perry A.M., Ton-That H., Mazmanian S.K., Schneewind O. Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring. J Biol Chem. 277:2002;16241-16248. Sortase anchors surface proteins to Lipid II. These Lipid-II-linked polypeptides are then incorporated into peptidoglycan.
22. Ruzin A., Severin A., Ritacco F., Tabei K., Singh G., Bradford P.A., Siegel M.M., Projan S.J., Shlaes D.M. Further evidence that a cell wall precursor [C55-MurNAc-(peptide)-GlcNAc] serves as an acceptor in a sorting reaction. J Bacteriol. 184:2002;2141-2147. This paper also presents evidence that sortase anchors surface proteins to Lipid II.
23. Guder A., Wiedemann I., Sahl H-G. Posttranslationally modified bacteriocins - The lantibiotics. Biopolymers. 55:2000;62-73.
24. Brotz H., Sahl H-G. New insights into the mechanism of action of lantibiotics - diverse biological effects by binding to the same molecular target. J Antimicrob Chemother. 46:2000;1-6.
25. Somner E.A., Reynolds P.E. Inhibition of peptidoglycan biosynthesis by ramoplanin. Antimicrob Agents Chemother. 34:1990;413-419.
26. Brotz H., Josten M., Wiedemann I., Schneider U., Gotz F., Bierbaum G., Sahl H-G. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol. 30:1998;317-327.
27. Lo M., Men H., Branstrom A., Helm J., Yao N., Goldman R., Walker S. A new mechanism of action proposed for ramoplanin. J Am Chem Soc. 122:2000;3540-3541. This article shows that ramoplanin blocks the polymerization of Lipid II in addition to the formation of Lipid II. It was proposed that ramoplanin inhibits bacterial transglycosylases, as well as MurG. Ramoplanin was also shown to bind a soluble Lipid II analogue with unexpected results.
28. Lo M-C., Helm J.S., Sarngadharan G., Pelczer I., Walker S. A new structure for the substrate-binding antibiotic ramoplanin. J Am Chem Soc. 123:2001;8640-8641.
29. Cudic P., Kranz J.K., Behenna D.C., Kruger R.G., Tadesse H., Wand A.J., Veklich Y.I., Weisel J.W., McCafferty D.G. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Proc Natl Acad Sci USA. 99:2002;7384-7389.
30. McCafferty D.G., Cudic P., Yu M.K., Behenna D.C., Kruger R. Synergy and duality in peptide antibiotic mechanisms. Curr Opin Chem Biol. 3:1999;672-680.
31. Wiedemann I., Breukink E., van Kraaij C., Kuipers O.P., Bierbaum G., de Kruijff B., Sahl H-G. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem. 276:2001;1772-1779. An explanation for the high bacteriocidal activity of nisin against Gram-positive bacteria, relative to other antimicrobial peptides is presented in this article. Nisin is proposed to bind to Lipid II and kill bacterial cells by two mechanisms of action.
32. Hsu S-T., Breukink E., de Kruijff B., Kaptein R., Bonvin A.M.J.J., van Nuland N.A.J. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles. Biochemistry. 41:2002;7670-7676.
33. Ge M., Chen Z., Onishi H.R., Kohler J., Silver L.L., Kerns R., Fukuzawa S., Thompson C., Kahne D. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science. 284:1999;507-511.
34. Kerns R., Dong S.D., Fukuzawa S., Carbeck J., Kohler J., Silver L., Kahne D. The role of hydrophobic substituents in the biological activity of glycopeptide antibiotics. J Am Chem Soc. 122:2000;12608-12609.
35. Evans D.A., Wood M.R., Trotter B.W., Richardson T.I., Barrow J.C., Katz J.L. Total syntheses of vancomycin and eremomycin aglycons. Angew Chem Int Ed Engl. 37:1998;2700-2704.
36. Thompson C., Ge M., Kahne D. Synthesis of vancomycin from the aglycon. J Am Chem Soc. 121:1999;1237-1244.
37. Nicolaou K.C., Mitchell H.J., Jain N.F., Winssinger N., Hughes R., Bando T. Total synthesis of vancomycin. Angew Chem Int Ed Engl. 38:1999;240-244.
38. Boger D.L., Miyazaki S., Kim S.H., Wu J.H., Castle S.L., Loiseleur O., Jin Q. Total synthesis of the vancomycin aglycon. J Am Chem Soc. 121:1999;10004-10011.
39. Boger D.L., Kim S.H., Mori Y., Weng J-H., Rogel O., Castle S.L., McAtee J.J. First and second generation total synthesis of the teicoplanin aglycon. J Am Chem Soc. 123:2001;1862-1871.
40. Losey H.C., Peczuh M.W., Chen Z., Eggert U.S., Dong S.D., Pelczer I., Kahne D., Walsh C.T. Tandem action of glycosyltranferases in the maturation of vancomycin and teicoplanin aglycones: novel glycopeptides. Biochemistry. 40:2001;4745-4755. Glycosyltransferases are used to make a set of unnatural glycopeptides efficiently.
41. Evans D.A., Katz J.L., Peterson G.S., Hintermann T. Total synthesis of teicoplanin aglycon. J Am Chem Soc. 123:2001;12411-12413.
42. Jiang W., Wanner J., Lee R.J., Bounaud P-Y., Boger D.L. Total synthesis of the ramoplanin A2 and ramoplanose aglycon. J Am Chem Soc. 124:2002;5288-5290.
43. Fukase K., Kitazawa M., Sano A., Shimbo K., Horimoto S., Fujita H., Kubo A., Wakamiya T., Shiba T. Synthetic study on peptide antibiotic nisin. v. total synthesis of nisin. Bull Chem Soc Jpn. 65:1992;2227-2240.
44. Okeley N.M., Zhu Y., van der Donk W.A. Facile chemoselective synthesis of dehydroalanine-containing peptides. Org Lett. 2:2000;3603-3606.
45. Zhou H., van der Donk W.A. Biomimetic stereoselective formation of methyllanthionine. Org Lett. 4:2002;1335-1338.
46. Schwartz B, Markwalder JA, Seitz SP, Wang Y, Stein RL: A kinetic characterization of the glycosyltransferase activity of Eschericia coli PBP1b and development of a continuous fluorescence assay. Biochemistry 2002, 41:in press.
47. Helm JS, Chen L, Walker S: Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan synthesis. J Am Chem Soc 2002, 124:in press.